Designed.

immunitoAI is a TechBio company developing AI-generated novel antibody therapeutics with pre-defined drug properties.

Our vision is to unleash the full potential of antibody-based biological drugs and make antibody therapy the norm.


Our AI platform generates novel antibody therapeutics with predefined drug characteristics for any protein target, validated through in-house biological methods.

immunitoAI's foundational pillars: 

Design over Discovery, Drug-First Antibody, Structure-First AI Platform

   Design over Discovery

Drug-First Antibodies

Structure-First AI Platform

Join immunitoAI in our journey of "Making Antibody Therapy the Norm".